Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Ten Haaf

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Thorax|October 30, 2021
Selection of eligible participants for screening for lung cancer using primary care dataEmma L O'Dowd, Kevin Ten Haaf, Jaspreet Kaur, et al.
JAMA|March 9, 2021
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task ForceRafael Meza, Jihyoun Jeon, Iakovos Toumazis, et al.
Journal of the National Cancer Institute|October 1, 2019
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening StrategiesKevin Ten Haaf, Mehrad Bastani, Pianpian Cao, et al.
Thorax|July 2, 2016
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening intervalUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
JAMA Oncology|October 21, 2021
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer ScreeningIakovos Toumazis, Koen de Nijs, Pianpian Cao, et al.
International Journal of Cancer|January 11, 2017
The impact of overdiagnosis on the selection of efficient lung cancer screening strategiesSummer S Han, Kevin Ten Haaf, William D Hazelton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 13, 2024
The Impact of Model Assumptions on Personalized Lung Cancer Screening RecommendationsKevin Ten Haaf, Koen de Nijs, Giulia Simoni, et al.
Annals of Internal Medicine|February 6, 2023
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness AnalysisIakovos Toumazis, Pianpian Cao, Koen de Nijs, et al.
JNCI Cancer Spectrum|June 1, 2022
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort StudyJacqueline V Aredo, Eunji Choi, Victoria Y Ding, et al.
Thorax|December 29, 2018
Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening studyJoan E Walter, Marjolein A Heuvelmans, Kevin Ten Haaf, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Thorax|October 30, 2021
Selection of eligible participants for screening for lung cancer using primary care dataEmma L O'Dowd, Kevin Ten Haaf, Jaspreet Kaur, et al.
JAMA|March 9, 2021
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task ForceRafael Meza, Jihyoun Jeon, Iakovos Toumazis, et al.
Journal of the National Cancer Institute|October 1, 2019
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening StrategiesKevin Ten Haaf, Mehrad Bastani, Pianpian Cao, et al.
Thorax|July 2, 2016
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening intervalUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
JAMA Oncology|October 21, 2021
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer ScreeningIakovos Toumazis, Koen de Nijs, Pianpian Cao, et al.
International Journal of Cancer|January 11, 2017
The impact of overdiagnosis on the selection of efficient lung cancer screening strategiesSummer S Han, Kevin Ten Haaf, William D Hazelton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 13, 2024
The Impact of Model Assumptions on Personalized Lung Cancer Screening RecommendationsKevin Ten Haaf, Koen de Nijs, Giulia Simoni, et al.
Annals of Internal Medicine|February 6, 2023
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness AnalysisIakovos Toumazis, Pianpian Cao, Koen de Nijs, et al.
JNCI Cancer Spectrum|June 1, 2022
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort StudyJacqueline V Aredo, Eunji Choi, Victoria Y Ding, et al.
Thorax|December 29, 2018
Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening studyJoan E Walter, Marjolein A Heuvelmans, Kevin Ten Haaf, et al.
Pageof 8